Drugs / gadollinum
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT01359345 Background | Jul 2008 → May 2011 | kidney failure, nephrogenic systemic fibrosis | Imam Khomeini Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gadollinum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01359345 ↗ |
| Modality | Diagnostic / imaging agent | “for imaging” NCT01359345 ↗ |
| Route | Intravenous | “gadollinum Iv” NCT01359345 ↗ |